- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01191632
Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases
Randomised Controlled Phase I/II Trail to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation Therapy in Resectable Colorectal Liver Metastases Patients
The efficiency of T cell based immunotherapies is affected by the insufficient migration and activity of tumor specific effector T cells in the tumor. Aim of this phase I/II clinical trial is to evaluate whether a neoadjuvant, low dose radiotherapy can improve T cell connected anti tumor immune response in colorectal liver metastases.
The primary endpoint is the number of tumor infiltrating T cells. Furthermore the T cell activity in situ, the number of regulatory T cells and the frequency of tumor reactive T cells in the blood and bone marrow will be examined.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Förväntat)
Fas
- Fas 2
- Fas 1
Kontakter och platser
Studieorter
-
-
-
Heidelberg, Tyskland, 69120
- Rekrytering
- University of Heidelberg
-
Kontakt:
- Juergen Weitz
- Telefonnummer: +49 6221 56 6250
- E-post: juergen.weitz@med.uni-heidelberg.de
-
Kontakt:
- Christoph Reissfelder
- Telefonnummer: +49 6221 56 6250
- E-post: christoph.reissfelder@med.uni-heidelberg.de
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Ability of subject to understand character and individual consequences of the clinical trial
- Written informed consent (must be available before enrolment in the trial)
- Age ≥ 50 years
- Radiological urgently suspected colorectal liver metastasis
Exclusion Criteria:
- second malignancy
- Pregnancy and lactation
- no prior liver radiation
- liver metastasis must be resectable
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Radiation 0,5Gy
Radiation: one time Radiation with an intensity of 0.5 Gy Group A Beginning on a weekday 48 hours before surgery |
Radiation: one time Radiation with an intensity of 0.5 Gy Group A 2.0 Gy Group B 5 Gy Group C Beginning on a weekday 48 hours before surgery |
Aktiv komparator: No radiation
Control group with 0Gy radiation
|
Control group with 0Gy
|
Aktiv komparator: Radiation 2Gy
Radiation: one time Radiation with an intensity of 2.0 Gy Group B Beginning on a weekday 48 hours before surgery |
Radiation: one time Radiation with an intensity of 0.5 Gy Group A 2.0 Gy Group B 5 Gy Group C Beginning on a weekday 48 hours before surgery |
Aktiv komparator: Radiation 5Gy
Radiation: one time Radiation with an intensity of 5 Gy Group C Beginning on a weekday 48 hours before surgery |
Radiation: one time Radiation with an intensity of 0.5 Gy Group A 2.0 Gy Group B 5 Gy Group C Beginning on a weekday 48 hours before surgery |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Purpose of the study is the determination of an active local external beam radiotherapy dose leading to a maximal number of tumor infiltrating T-cells. The total T-cell activity serves as primary surrogate parameters for anti- tumor activity
Tidsram: 2 years
|
2 years
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
To determine local control and recurrence patterns of colorectal liver metastases in a CT
Tidsram: 2 years
|
2 years
|
To determine the progression-free survival in patients treated with low dose photon beam radiation therapy
Tidsram: 2 years
|
2 years
|
• To determine the surgical morbidity in patients undergoing liver resection who received this protocol treatment
Tidsram: 2 years
|
2 years
|
• To determine 30-day post-operative mortality after liver resection in patients who received this protocol treatment
Tidsram: 2 years
|
2 years
|
• To determine the T-cell activity in the resected liver tissue
Tidsram: 2 years
|
2 years
|
• To determine quality of life according to the EORTC QoL questionnaire after 6 months.
Tidsram: 6 months
|
6 months
|
To determine the number of regulatory T-cells in the resected liver tissue
Tidsram: 2 years
|
2 years
|
To determine the frequencies of tumor-reactive T-cells in the blood and bone marrow of the patients
Tidsram: 2 years
|
2 years
|
To determine quality of life according to the EORTC QoL questionnaire after 12 months.
Tidsram: 1 year
|
1 year
|
To determine the number of patients with adverse events as a measure of safety and tolerability according to CTCAE, Version 4.0 criteria
Tidsram: 2 years
|
2 years
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- S081/2008
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Kolorektala levermetastaser
-
Universidad Complutense de MadridRekrytering
-
Sisli Hamidiye Etfal Training and Research HospitalHar inte rekryterat ännuErfarenhet, livKalkon
-
Bournemouth UniversityDorset County Hospital NHS Foundation TrustAvslutadErfarenhet, livStorbritannien
-
Centre Hospitalier Universitaire DijonAvslutad
-
Diakonie Kliniken ZschadraßChemnitz University of TechnologyAvslutadMantra Meditation | Mantra Meditation + Kroppsorienterad Yoga | Mantra Meditation + Etiskt Liv | Mantra Meditation + Kroppsorienterad Yoga + Etiskt livTyskland
-
University of California, Los AngelesVA Greater Los Angeles Healthcare SystemIndragenVeteranfamiljer | Familjekommunikation | Återintegrering av civilt livFörenta staterna
-
University of AthensKing's College Hospital NHS Trust; Charite University, Berlin, Germany; University...Har inte rekryterat ännuSlutet av liv
-
The Roots to Thrive Society for Psychedelic TherapyVancouver Island Health Authority; Vancouver Island UniversityHar inte rekryterat ännu
-
The Hong Kong Polytechnic UniversityRekrytering
-
Fondazione Policlinico Universitario Agostino Gemelli...Rekrytering
Kliniska prövningar på one time radiation
-
University of LouisvilleAvslutadDepressiva symtom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldAvslutad
-
University Hospital, GrenobleRemedee SA; Clinical Investigation Centre for Innovative Technology NetworkAvslutadInnovativ enhet för smärtlindring med millimeterstrålning: Elektronisk smärtlindring. (Epikarthrose)Smärta | Artros | KringutrustningFrankrike
-
Alpha Tau Medical LTD.RekryteringProstata AdenocarcinomIsrael
-
Alpha Tau Medical LTD.RekryteringLungcancer | Återkommande lungcancerIsrael
-
Alpha Tau Medical LTD.RekryteringHudcancer | Slemhinneneoplasma i munhålan | Neoplasma i mjuk vävnadIsrael
-
Alpha Tau Medical LTD.RekryteringHudcancer | Slemhinneneoplasma i munhålan | Neoplasma i mjuk vävnadItalien
-
Alpha Tau Medical LTD.Aktiv, inte rekryterandeHudcancer | Slemhinneneoplasma i munhålan | Neoplasma i mjuk vävnadIsrael
-
Inje UniversityAvslutad
-
Alpha Tau Medical LTD.RekryteringHudcancer | Slemhinneneoplasma i munhålan | Neoplasma i mjuk vävnadIsrael